STANLEY KOLESZAR: Open Payments
NPI 1972571354 · PUTNAM, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 43 payments from 20 companies in 2025. Trend: 2023 $739 · 2024 $798 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $141 |
| PFIZER INC. | 5 | $101 |
| Axsome Therapeutics, Inc. | 3 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Exact Sciences Corporation | 2 | $58 |
| GlaxoSmithKline, LLC. | 2 | $51 |
| Lilly USA, LLC | 2 | $46 |
| ABBVIE INC. | 2 | $44 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
Products named: ELIQUIS, Rybelsus, JARDIANCE, Ozempic, Sunosi, Cologuard Collection Kit, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across CT — which companies pay providers there.
